GlassScriptPrepare for your visit
Nithya Cherukuru
Psychiatry · Philadelphia, PA · NPI 1578925442
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$437.81
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 5 by amount.
- Alkermes, INC. $194.10
- Teva Pharmaceuticals USA, INC. $119.25
- Sunovion Pharmaceuticals INC. $100.11
- Vanda Pharmaceuticals INC. $13.19
- Neurocrine Biosciences, INC. $11.16
Drugs and devices associated with these payments
Austedo Xr
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Nithya Cherukuru listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/5702107/nithya-cherukuru